Swindon-based Eastcott Veterinary Referrals is looking for a new resident to join its dentistry team.
Eastcott’s dentistry department is led by Andrew Perry, an EBVS European Veterinary Specialist in Dentistry. He's supported by Peter Southerden, AVDC Founding Fellow in Oral and Maxillofacial Surgery – one of only 14 founding fellows in the world and the only one practicing in Europe.
The residency programme will offer an in-depth knowledge in veterinary dentistry through a mix of clinical and non-clinical work.
It will also provide an opportunity to work alongside world class surgeons responsible for some of the most advanced dental surgical procedures of today.
The clinical aspect of the role will require the candidate to manage cases and perform all forms of dental and oral surgical procedures and client communication, with guidance from senior staff.
The role will also involve preparation of scientific articles for publication and will help develop the candidate's teaching and presenting skills and externships in diagnostic imaging, surgery and anaesthesia.
Andrew said: “The team at Eastcott are proud to be a part of developing future specialists in a discipline that is growing rapidly and has such an impact on patient welfare.
“Our multidisciplinary approach to management of dental, oral and maxillofacial pathologies means that the successful candidate will have the benefit of exposure to a very diverse, and at times cutting edge, caseload.
“The residency programme is well-established at Eastcott. The dentistry, oral and maxillofacial team, the hospital directors and the Linnaeus central support team are committed to individual development and growth and work hard to provide an environment and support to allow our residents to flourish.”
For more information on this role, visit www.eastcottreferrals.co.uk or email andrew.perry@eastcottvets.co.uk before July 31.
The support packs include a social media toolkit with graphics for practices to use on their own social media channels.
Visitors to the company's stand at the London Vet Show will also be able to sign up to receive a Practice Pet Protection Pack which contains a detail aid, a general microchipping leaflet, a law guides for horses, dogs and cats, and puppy and kitten leaflets.
https://identichip.co.uk
The event is being hosted by Luke Gamble as part of the company's ‘Advocates of Knowledge’ series, and there are £400 worth of prizes to be won:
Advocate Senior Brand Manager Vicky McAlister said: “We want to ensure that we’re delivering CPD in an engaging way, so that vets are still able to upskill in these areas, whilst also being able to engage with other vets in the industry, which is especially important given current times.
"Following the success of the first event, we’re pleased to be back again to host another and are committed to continuing to support CPD progression.”
To register for the event, visit: https://www.eventbrite.co.uk/e/113870170746
The figures, published as part of the RSPCA's Cancel Out Cruelty campaign, showed that the UK's 12 million dogs are over four times more likely to be the victims of intentional harm compared to cats, about which there were 14,825 incident reports.
There were also 3,226 incidents of deliberate harm to horses and 811 to rabbits.
RSPCA dog welfare expert Dr Samantha Gaines said: “We say we’re a nation of animal-lovers and that dogs are man’s best friend. And yet, every year, we see many dogs coming into our care bearing the physical and mental scars that were inflicted at the hands of the very people who were meant to keep them safe and love them unconditionally.
"Some of the cases I’ve seen have left me in tears and still stay with me today. Every time my own RSPCA rescue dog, Flo, comes to curl up beside me on the sofa I wonder what she suffered at the hands of people before she was found wandering the streets of London with a badly broken leg. Did someone do that to her deliberately? It doesn’t bear thinking about.
"But, tragically, that’s the reality for so many dogs. We’ve seen some of the most unimaginable cruelty inflicted on these gentle, sweet creatures. We’ve seen them beaten, drowned, set on fire, and poisoned. Our officers have been able to save some of them; getting to them just in time and finding them collapsed, bloodied, and hopeless. Others have died at the hands of their tormentors, but none should experience such cruelty.”
For more information, visit: www.rspca.org/stopcruelty.
In contrast to the British Veterinary Association, The National Office of Animal Health (NOAH) has welcomed the decision by DEFRA not to proceed with the proposal contained in the draft Veterinary Medicines Regulations 2010 to prohibit the advertising of antimicrobials to farmers.
NOAH says it believes the proposal would have had a negative effect on farmers' ability to maintain their knowledge and awareness of animal health and welfare issues, and did not believe that it would reduce antimicrobial resistance profiles.
NOAH chief executive Phil Sketchley said: "Farmers, as professional producers of food, need to be kept well briefed on the antimicrobials they use, following prescription by their veterinary surgeons. Promotion by our members plays a key role in this and in educating farmers about animal welfare and disease."
NOAH members follow rigid rules on advertising and promotion through the longstanding Code of Practice for the Promotion of Animal Medicines.
Phil added: "The NOAH Code already goes beyond the Veterinary Medicines Regulations and is reviewed each year - this year we will be particularly looking to ensure that it fully reflects the industry's commitment to disease education and information on responsible use, particularly in relation to antimicrobial promotion. We have planned, at our Code review meeting in February, further discussions within NOAH and with the VMD to finalise how this can best be achieved.
"Importantly we must always remember that antimicrobial medicines for all animals are POM-V, meaning they have to be prescribed by a veterinary surgeon, and therefore it should be the vet who makes the decision on whether an antibiotic is needed. If such therapy is indicated, the most appropriate antibiotic for an animal or group of animals is selected by the veterinary surgeon based on the clinical signs shown, the current disease situation on the farm and in the area and where appropriate and feasible, is based on bacterial culture and sensitivity testing."
Using promotion to encourage responsible use, NOAH launched its 'Use Medicines Responsibly' campaign in 2009. A recommendation was made that members include a strap line on promotional material advising users to 'use medicines responsibly'.
NOAH was a founder member of the Responsible Use of Medicines in Agriculture Alliance (RUMA) and continues to be a strong contributor to and supporter of RUMA's communications to farmers including the antimicrobial guidelines. These guidelines are not intended to influence the veterinary surgeon's decision to prescribe but help support ways that the veterinary surgeon and farmer can work together to reduce the need to prescribe antimicrobials whilst ensuring they are used responsibly once prescribed in line with the principle of 'as little as possible but as much as necessary'.
Phil said: "Antibiotics are essential for the health and welfare of the UK's livestock population. NOAH accepts that antimicrobial resistance is a serious and growing subject of discussion for the medical and veterinary professions and we need to continue to take this matter seriously."
Dechra Pharmaceuticals has signed an agreement with Piedmont Pharmaceuticals LLC which gives Dechra exclusive worldwide rights to the sale and distribution of veterinary products which use Piedmont's proprietary soft chew platform to deliver the active ingredient.
The agreement will allow Dechra to conduct studies necessary to achieve regulatory filings and government approvals within the US, Europe and other key countries.
According to Dechra, Piedmont's soft chew formulation is a unique delivery technology which overcomes the traditional problems in formulating a broad range of active drug compounds in a highly palatable chewy treat for both cats and dogs.
Ian Page, CEO of Dechra Pharmaceuticals PLC, said: "We are very excited about licensing this unique delivery technology, which will be the first soft chew product with this new patent pending technology in the veterinary market. The agreement will provide Dechra with the opportunity to expand our presence in the companion animal market with a truly differentiated product."Roland Johnson, Chairman and CEO of Piedmont Pharmaceuticals, said: "This is our initial development partnership for our soft chew technology and we welcome the opportunity to license our technology to Dechra. Our goal is to provide pet owners the added benefit of a tasty treat at medicine time, creating a fun and rewarding interaction, while improving compliance with the vet prescribed treatment regimen."
CEVA Animal Health has published a trial which, according to the company, shows that horses suffering lameness caused by bone spavin can show marked improvement following treatment with a Tiludronate infusion, in combination with controlled exercise.
Bone spavin is a chronic aseptic osteoarthritis of the distal tarsal joints which, says CEVA, is considered to be one of the most common forms of hindlimb lameness in the horse.
The double-blind, multicentric, placebo-controlled trials were carried out on a total of 108 pleasure horses, show jumpers and eventers of a variety of sizes and breeds, all of which had been clinically diagnosed with bone spavin. The horses were rigorously selected, having to show clinical signs of spontaneous lameness of at least six weeks but less than a year's duration and had to be in daily exercise. Horses suffering proximal suspensory desmitis were excluded.
Horses were defined as suffering from bone spavin if they displayed a chronic hindlimb lameness which improved with distal tarsal joint analgesia and showed radiographic evidence of bony changes associated with bone spavin in the distal tarsal joints. The horses were treated at day zero with a single Tiludronate infusion or a placebo and reassessed 60 days later after a period of controlled exercise.
Eighty seven horses completed the trials, comprising 42 Tiludronate treated horses and 45 placebo cases. By day 60 approximately 60% of the Tiludronate treated horses had improved in lameness by two grades or more, scored on a ten point system.
Horses with bone spavin experience abnormal bone remodeling changes, occasionally with excessive bone resorption in the tarsal bones. Tiludronate works by regulating this bone remodeling through a decrease in the resorptive process, slowing down the degradation of the bone structure when the condition is progressing and alleviating the pain associated with abnormal bone lysis.
CEVA has recently produced a leaflet specifically to help horse owners to understand the diagnosis and treatment of bone spavin. For copies of this leaflet and CEVA's comprehensive veterinary brochure on the product please contact CEVA Animal Health on 01494 781510 or visit the website at http://www.tildren.com/
Tiludronate infusion in the treatment of bone spavin: A double blind placebo-controlled trial
Reference M. R. GOUGH*, D. THIBAUD† and R. K. W. SMITH‡ (*CEVA Animal Health, Bucks, UK; †CEVA Animal Health USA, Kansas, USA; and ‡Department of Veterinary Clinical Sciences, The Royal Veterinary College, University of London, UK). Equine vet. J. (2010) 42 (5) 381-387 doi: 10.1111/j.2042-3306.2010.00120.x
A YouGov poll commissioned at the start of this month's National Vaccination Month Campaign by Intervet/Schering-Plough Animal Health has shown that pet vaccination rates nationally have remained stable between 2009 and 2011 despite the recession.
This could suggest that pet owners who do vaccinate generally accept that vaccination is not a discretionary item of spending which can be dropped in financially hard times. This is in contrast to worming, pet insurance and health checks, things which the survey found that between 6% and 9% of owners have cut back on.
Nevertheless, the survey supported industry data which shows that very considerable numbers of Britain's pets are left unvaccinated, with strong regional variations:
According to the YouGov survey, cost is a factor in more than 39% of cases where owners of a cat, dog, rabbit or horse are failing to vaccinate.
However, during National Vaccination Month, pet owners can download a voucher for a discounted vaccination offering savings of around £30 from participating surgeries throughout May. Unvaccinated and eligible dogs, cats, rabbits and horses are all included in the scheme and more than 2000 vet practices are taking part in the campaign nationwide.
Angus Robinson from Intervet/Schering-Plough Animal Health said: "The survey suggests that not only is there a demand for National Vaccination Month - 76% of those not vaccinating said they would take advantage of a scheme like this. But there is also a real need for client education. A staggering 91% of those polled said they would get their pet vaccinated if they were aware that there was disease in their area. Without wishing to scare people, we do need to alert pet owners to the fact that pet disease is out there. It is the kind of thing that they never think is going to happen to their beloved pet but when it does, it is devastating."
Rowe Referrals, part of IVC Evidensia Referrals, was one of the very first practices to have an onsite MRI when it installed a 1.5T model five years ago. Now, thanks to investment from IVC Evidensia - of which it is a part - Rowe has been able to replace the ageing model with a new 3.0T machine, which will enable clinicians to diagnose and implement treatment plans quicker.
Referrals Manager at Rowe Referrals, Meg Hayman, said: "The difference between the two machines in amazing. The 1.5T produced very detailed scans but the 3.0T is incredible! It gives our clinicians the ability to perform more complex investigations with far greater clarity.
The practice says benefits will be seen across all disciplines, including neurology, internal medicine, ophthalmology, dentistry, orthopaedics and soft tissue.
Ian Jennings BSc BVSc CertVDI MRCVS RCVS Advanced Practitioner in Diagnostic Imaging said: "The new 3.0T MRI scanner allows us a much more detailed view of our patients, and has been especially useful for detection of smaller lesions in our neurological and orthopaedic cases. Specialised sequences can also be performed in less time, allowing us a greater ability to help more patients."
40% of Brits are more likely to trust their vet's advice above that of other health practitioners such as GPs, dentists and opticians, according to research announced today by Petplan.
The younger generation are the least trusting in their human healthcare providers with a resounding majority of those surveyed in the 16 to 24 age group saying they are most likely to trust their vet's advice over their doctor's.
Nationally, nearly four out of ten pet owners put more faith in vets than doctors, rising to 7 in 10 in some parts of the country.
Talking of which, my mother needs a new hip. Any of you up for it?
The man was arrested on Sunday 4th September in connection with six burglaries, all of which occurred overnight between 22 August and 3 September at practices in Esher, West Molesey, East Molesey and Claygate.
The police say entry was gained by smashing windows (so, not what you'd call a cat burglar, then). Various items were stolen, including money and medication. There were also a number of unsuccessful break-in attempts.
Detective David Thomas, who is investigating the offences, said: "Although we have made an arrest in relation to these burglaries, I am still appealing for anyone who has seen anything suspicious in the vicinity of a vets surgery recently, or with any other information which could help to progress the investigation. I would also like to speak to anyone who has come across any discarded cash boxes or safes or been offered any cut price veterinary drugs."
If you can help, please call Surrey Police on 101, quoting master crime reference number 45160072203 or you can use the online reporting system found at https://report.police.uk/ and enter the reference number in the ‘Additional information' section.
If you do not want to leave your name the independent charity Crimestoppers can be contacted on 0800 555 111.
There are 13 candidates standing in this year’s election for RCVS Council, the voting period for which will open on the week commencing Monday 14 March and close at 5pm on Friday 22 April 2022.
The candidates are:
The full biographies and manifesto statements for each candidate are available to read at www.rcvs.org.uk/vetvote22.
To submit a question to the candidates, email: vetvote22@rcvs.org.uk or post it on the RCVS Twitter account (@theRCVS) using the hashtag #vetvote22.
Candidates will then be asked to record a short video of themselves answering two questions of their choice which will be published when the election starts.
You have until Monday 21 February 2022 to submit your question.
There are 10 candidates standing this year and vets can vote for up to three of them until 5pm on Friday 21st April 2023:
The biographies and statements for each candidate are available at www.rcvs.org.uk/vetvote23 where each candidate has also answered two questions of their choice submitted by members of the profession.
The three candidates who receive the most votes will take up their four-year terms on RCVS Council at the RCVS Annual General Meeting on Friday 7th July 2023.
Any veterinary surgeons who have not received their voting email should contact CES directly on support@cesvotes.com stating which election they intend to vote in.
There are two main streams – veterinary and nursing – alongside which there will be a number of workshops on dentistry, ophthalmology, electrosurgery and wound management
Speakers will include: Alasdair Hotston Moore, Matthew Oxford, David Williams, Sarah Heath and Molly Varga.
New for this year, there will be a separate two-day SPVS Leadership & Management programme (at extra charge) and interactive mental health sessions run by Vets in Mind.
There will also be sessions run by SCAS/Our Special Friends on 'the bond-centred practice'.
There's a commercial exhibition, a happy hour on day one, a hot buffet lunch, and tea, coffee and biscuits throughout both days.
For overnight accommodation, the organisers have secured a preferential rate (£125) at the on-site hotel – the Courtyard by Marriott – that includes breakfast and parking.
To book, use this link: https://www.marriott.com/event-reservations/reservation-link.mi?id=1709042444468&key=GRP&app=resvlink. There are lots of other options nearby.
Book directly at https://form.jotform.com/240863511432349.
To be invoiced rather than pay now, apply INVOICEME at checkout.
www.vetcpdcongress.co.uk.
Merial Animal Health, makers of Previcox® have launched a new technical manual containing expert thinking on canine osteoarthritis (OA) and other orthopaedic subjects.
Recipients will also have the opportunity to test themselves and their colleagues on the technical content for their chance to win £500 worth of CPD vouchers.
Previcox product manager Claire Parry-Baggott said: "We have been very fortunate in being able to work with some of the UK's most highly regarded experts in the field of OA.
"The first issue just released contains two papers, the first from Gareth Clayton-Jones, BVetMed DVR DSAO HonFRCVS, RVC specialist in both small animal othopaedics and diagnostic imaging. Mr Jones discusses anterior cruciate ligament rupture, including examination, radiography and treatment options.
"The second paper in this first edition is from specialist in small animal orthopaedics Prof. John Innes BVSc PhD CertVR DSAS(orth) MRCVS, of the University of Liverpool, who looks at elbow dysplasia. In his paper Professor Innes provides a detailed but practical guide to the condition."
Additionally to support Gareth Clayton-Jones' first issue there is a DVD highlighting common clinical presentations of dogs suffering from stifle disease.
Claire said: "With two papers in this first issue there's a total of £1,000 of CPD vouchers up for grabs."
"Each paper has a related quiz containing key questions from the discussion. The winner will be the first correct entry drawn at random," she explains. "Other topics to be covered in the series include Osteochondritis Dissecans (OCD); pain and analgesics; rehabilitation; hips; and spines.
"The manual is set to provide a comprehensive, up-to-date practical guide to OA and related conditions. Subsequent papers will be issued on a quarterly basis and will also contain a quiz sheet with the opportunity to win £500 of CPD vouchers," concludes Claire.
If you haven't already received your copy, contact your local Merial territory manager or call the customer hotline on 0870 6000 123.
Ceva Animal Health UK has launched a range of support materials to help educate veterinary professionals and cat owners about feline stress and the benefits of using Feliway.
For veterinary surgeons and nurses, the company has produced a series of video presentations by the Specialist in Feline Medicine, Danielle Gunn-Moore, in which she discusses feline stress and its link to cystitis. The videos are now available to watch here on VetSurgeon.org.
Also for veterinary surgeons, the company has produced an A3 decision tree featuring the practical approach to cystitis, developed by Danielle Gunn-Moore. In addition, there's a waiting room poster which details what resources are needed to create a cat-friendly home. The resource checklist consists of advice on basic resources such as food, water bowls and litter trays and hints and tips on how to reinforce confidence, develop structural features, stimulate activity and provide appropriate resources for a multi-cat household.
For owners, Ceva has produced a post-operative cat care information sheet. It is a question and answer style document covering advice on caring for a post-operative cat when it returns home.
To help highlight the benefits of Feliway, Ceva is also running a prize draw to win one of three Kindles, with three runners-up winning a Feline Infectious Disease book.
For further information on the new Feliway support materials or the prize draw, please contact your local Ceva account manager or telephone 01494 781510.
The Association says continuing uncertainty over the pandemic was the driving force behind the decision and it feels that a virtual Congress is the best option in 2021. The event will be held from Thursday 25th – Saturday 27th March.
Amanda Stranack, Chief Executive of the BSAVA, said: “A rich programme of content that makes full use of technology means attendees can still expect an event that brings together the veterinary professions for world-class CPD and the opportunity to network with delegates.
"Making this decision now means we can be sure there will be a safe and dedicated space for all our visitors, speakers, sponsors and exhibitors."
Manchester Central, the original venue for the 2021 Congress, is currently contracted as a Nightingale Hospital and that contract doesn’t conclude until 1st March 2021.
Amanda said: "While no one has a crystal ball, there is the possibility cases could increase over the winter and we cannot be certain the venue will be available to host our annual event.
"In order to ensure that delegates and exhibitors will have an excellent experience, moving Congress online is the most sensible option, without the need to worry about travel restrictions, or guidance that might change on a weekly basis.
"The positive is that without the need to travel Congress becomes accessible to a wider audience, with scope for more practitioners to attend more sessions. There’s a level of flexibility and convenience that’s just not possible with a physical event."
The BSAVA has partnered with a leading international provider of large-scale virtual conferences, tradeshows and exhibitions, with interactive elements facilitating one-to-one and group conversations.
The planned programme for 2021’s inaugural Manchester event is currently being repurposed for the virtual format, with a significant focus on ensuring the experience is as interactive as possible for each delegate.
Amanda said: “While we are deeply disappointed that we won’t, as a sector, be able to come together in person, we have made significant educational and financial investments in the online platform, to give us the tools to take the work we’ve been doing to deliver online CPD to the profession to a different level. We intend to make the most of that opportunity and provide a personalised experience, satisfy scientific curiosity and broaden horizons for all attendees.” Ian Ramsey, President of the BSAVA continued: “After months of lockdown, like many of our delegates, I was looking forward to meeting friends at the 2021 Congress at Manchester. Sadly, this is not to be, however BSAVA is going to be investing heavily in this project and I will be excited to welcome colleagues from the widest possible audience to what I think will be the best virtual small animal veterinary conference in the world. Of course, we are still also planning for a slow return to face- to-face events in the future when it is safe to do so, and more details will follow when there is greater clarity and confidence in physical events."
Cyclofin contains two active ingredients: 200 mg/ml of the anti-inflammatory flunixin-meglumine (eq. to 33.2 mg/ml flunixin meglumine) and 300 mg/ml of the class D anti-infective, oxytetracycline (eq. to 323.5 mg/ml oxytetracycline trihydrate).
Dechra says Cylofin acts within 24-36 hours and has sustained anti-bacterial activity for five to six days following a single intramuscular injection.
Administration is deep intramuscular injection in cattle and Cyclofin has a 35-day withdrawal period and a memorable dose rate of 1 ml per 10 kg body weight.
Alana McGlade MRCVS, national sales manager at Dechra, said: “BRD is one of the most prevalent and costly diseases on farm and early administration of an effective and fast-acting NSAID/antibiotic combination treatment, such as Cyclofin, can help relieve discomfort and stress, alleviate pain and improve demeanour and food intake.”
Cyclofin is available in 100ml vials.
https://www.dechra.co.uk/products/livestock/prescription/cyclofin#Cyclofin-300mg-ml.
Ki-67 is a proliferation marker used for assessing tumour aggressiveness, however the traditional method of assessing Ki-67 scores involves manually counting the proliferating cells, which is subjective, time-consuming and prone to variability.
Finn says its new AI-assisted Ki-67 scoring test represents a significant advancement in veterinary diagnostic oncopathology.
The AI algorithm analyses Ki-67 labelling across the entire section of tumour.
Positively labelled cells are highlighted, scores are calculated, and the results are validated by a pathologist before reporting.
This more automated analysis enables the evaluation of large volumes of histological data, ensuring consistent and reliable prognostic assessments.
Finn says it also removes the subjectivity and variability associated with identifying areas of highest cell proliferation, which is a crucial aspect of tumour scoring.
https://www.finnpathologists.com
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Nominations can be made for three RCVS Honours: the Queen’s Medal, the Golden Jubilee Award and Honorary Associateship.
The Queen’s Medal was introduced in 2013 and is the highest honour that the College can bestow upon a veterinary surgeon in recognition of those who have achieved a highly distinguished career and outstanding achievements. Nominations can be made by any Member of the RCVS in respect of another veterinary surgeon. The 2016 winner of the award was Professor Randolph Richards who was honoured for his contribution to the development of aquaculture in Scotland.
The Golden Jubilee Award was introduced in 2011 to mark the 50th anniversary of the first RCVS training course for veterinary nurses and now recognises those nurses who are taking a leadership role within the profession. The 2016 winner of the award was Louise O’Dwyer who was recognised for her pioneering role within the profession. Nominations can be made by either veterinary nurses or veterinary surgeons in respect of a veterinary nurse.
Nominations can also be made for Honorary Associateship which is eligible for those who, while not veterinary surgeons or nurses, have made a significant impact in the veterinary field. Previous winners have included scientists, farmers, farriers, educationalists and journalists. This year an Honorary Associateship was awarded to Professor David Lane for his support in launching the College’s Certificate in Advanced Veterinary Practice.
Further information about making nominations for each of these awards, including nominations forms, can be found at www.rcvs.org.uk/honours.
The deadline for nominations is Friday 16 September 2016 and all awards will be bestowed at RCVS Day 2017 in July next year.
Those with questions about making a nomination can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk.
The nomination period runs up until 5pm on Tuesday 31 January 2017. In order to stand, candidates need to submit a nomination form, submit a short biography and personal statement and supply a high resolution digital photo.
Each candidate also needs two nominators who are veterinary surgeons on the College’s Register but who are not current RCVS Council members.
Dr Chris Tufnell, RCVS President, said: "As someone who has been a member of Council since 2009 I can honestly say that the discussions you have and the decisions you make through both Council and its various committees do have a tangible impact on the future of the profession.
"For example, in my relatively short time as a Council member I have been involved in the review of specialisation in the profession and the setting up of Advanced Practitioner status, the championing of primary care as a valuable discipline in its own right and overseen the delivery of an ambitious Strategic Plan through my position on the Operational Board.
"These are all areas that I never imagined I’d be able to influence from my position as a practising vet in general practice. So, if you are interested in having a say in issues as varied as CPD policy and how we respond to the challenges and opportunities of Brexit, then please put yourself forward for Council."
Prospective candidates are invited to attend a ‘Meet the RCVS Day’ at the College’s offices in Belgravia House, London, on Wednesday 23 November 2016 where they will have the opportunity to talk to RCVS President Chris Tufnell and find out more about the role of the College, its Councils and its committees.
Those interested in attending should contact Emma Lockley, RCVS Events Officer, on e.lockley@rcvs.org.uk or 020 7202 0773. Reasonable expenses for travel will be reimbursed.
The election period starts around mid-March and will run until 5pm on Friday 28 April 2017. Ballot papers will be sent to veterinary surgeons who are eligible to vote in the week commencing Monday 13 March 2017.
Nomination forms, guidance notes and frequently asked questions for prospective RCVS Council candidates can be found at www.rcvs.org.uk/rcvscouncil17.
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
All entrants to the survey will also be able to enter a draw to win a £50 Amazon voucher.
Jenny Langridge (pictured), Editor of Veterinary Woman, said: “This is our third annual survey and we are seeking the opinions of both Veterinary Woman readers and the wider professions to highlight the key issues affecting women in the veterinary sector.
"We’re not just asking questions, we’re offering veterinary professionals a chance to take part in an ongoing conversation about the very real issues that women face in the veterinary workplace.
"The more diverse the information we can collate about these topics, the more we can work towards achieving changes that help for women to thrive in the professions.”
All data and responses will remain strictly anonymous.
https://bit.ly/vet-woman-readership-survey